SCHEMBL4617581

SCHEMBL4617581

NC(=O)CCNS(=O)(=O)c1cccc(S(=O)(=O)c2ccccc2)c1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.55
MEP1B Q16820 1/20 0.51
AKR1C3 P42330 1/20 0.49
CYP2C19 P33261 1/20 0.49
PRMT1 Q99873 2/20 0.48
ALDH1A1 P00352 5/20 0.48
TBXA2R P21731 1/20 0.48
KDM4E B2RXH2 2/20 0.46
LMNA P02545 2/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
SFRP1 Q8N474 1/20 0.46
GAA P10253 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
KMT2A Q03164 1/20 0.45
PKM P14618 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4617937 0.88 ATM (0.69) ATMMEP1BAKR1C3CYP2C19ALDH1A1
SCHEMBL3687106 0.86 ALDH1A1 (0.61) ATMMEP1BPRMT1ALDH1A1TBXA2R
SCHEMBL4618759 0.84 SFRP1 (0.68) ATMPRMT1ALDH1A1LMNASFRP1
SCHEMBL4616985 0.83 ALDH1A1 (0.56) ATMMEP1BAKR1C3CYP2C19ALDH1A1
SCHEMBL4801066 0.81 KMT2A (0.71) ATMAKR1C3ALDH1A1KMT2A
SCHEMBL4619610 0.79 MAPK1 (0.53) ATMAKR1C3CYP2C19ALDH1A1KDM4E
SCHEMBL7371174 0.78 ALDH1A1 (0.68) ALDH1A1LMNAGAASMN1; SMN2
SCHEMBL5183959 0.78 CA1 (0.58) ATMALDH1A1LMNAGAANPSR1
SCHEMBL3134057 0.78 ALDH1A1 (0.59) ATMMEP1BAKR1C3CYP2C19ALDH1A1
SCHEMBL4616767 0.78 ALDH1A1 (0.71) AKR1C3PRMT1ALDH1A1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP disclosed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 ATM 4812/4885MEP1B 1076/4885AKR1C3 4370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.